Why is Guanfacine not recommended for long-term use?
Although Guanfacine has shown certain efficacy in the treatment of attention deficit hyperactivity disorder (ADHD), from the perspective of pharmacological mechanism and clinical observation, it is not suitable for long-term high-dose use. Its essence is a central α2A adrenergic receptor agonist, which can reduce sympathetic nerve excitability, thereby achieving the effects of calming, stabilizing mood and improving attention. However, long-term use will cause tolerance problems, that is, the body gradually adapts to the effects of the drug, and the dose needs to be continuously increased to maintain the original effect. This may not only weaken the therapeutic effect but also increase the risk of adverse reactions.

Among the known side effects of guanfacine, the more common ones include drowsiness, low blood pressure, slowed heart rate, dizziness, and fatigue. If used for a long time, these reactions may be exacerbated and even affect daily learning and work efficiency. For adolescent patients, medications may lead to improved attention but also slowed thinking or decreased motivation to learn, thus negatively affecting academic performance. In addition, if a patient suddenly stops taking the drug after taking it for a long time, he may experience withdrawal-like reactions, such as a rebound increase in blood pressure, aggravation of anxiety, etc., which are potential danger signals for the cardiovascular system and nervous system. Therefore, most doctors will emphasize that guanfacine hydrochloride is suitable for use under clear indications and strict monitoring when prescribing, and do not recommend patients to rely on themselves for a long time.
Modern clinical trends emphasize comprehensive managementADHD and related diseases, that is, drug treatment is supplemented with psychological intervention, behavioral training and family support, rather than relying on drugs as the sole reliance. For patients who require longer-term management, doctors will regularly evaluate the effects of the medication and adjust the dosage or replace other types of medications if necessary.
Reference materials:https://go.drugbank.com/drugs/DB01018
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)